← Back
Novavax
NVAX · listed on Nasdaq · worth $1.66 billion
$10.08
−3.72% on Oct 30
No insider bought or sold Novavax stock on the market in the last year.
No insider trades or company news in this range.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
146.2M shares
89% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
No insider bought or sold Novavax stock on the market in the last year. The reports below are share awards and other paperwork.
Big investors
People and funds that reported owning 5% or more of Novavax, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company.Shah Capital Management6.4%Oct 16Reported stake, oldest first: 6.4% (Oct 16) → 6.4% (Oct 16)
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateShah Capital Management6.4%Oct 16
Each history starts at the oldest report we hold.
All reports
Every insider trade and SEC report we hold for Novavax.
Newest first
No one bought or sold NVAX on the market in these reports. Tick the box above to see the paperwork.
Analysts, earnings and news
Analysts' price target
$14.11 average
9 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q1 '26−$0.06 a share+$0.18
Q4 '25$0.11 a share+$0.60
Q3 '25−$1.25 a share−$0.08
Q2 '25$0.62 a share+$0.70